One‐year Acarbose Treatment Raises Fasting Serum Acetate in Diabetic Patients

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Diabetic Medicine

• Publication date

  1995-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1464-5491.1995.tb00448.xPMID 7743764
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oral Antidiabetic Agents

  2012cited by this paper
• The Diabetes Control and Complications Trial

  1998cited by this paper
• Differential Response of Plasma Lipoprotein(a) and Apolipoprotein B in NIDDM Subjects Treated With Acarbose

  1995cited by this paper
• The Efficacy of Acarbose in the Treatment of Patients with NonInsulin-Dependent Diabetes Mellitus: A Multicenter, Controlled Clinical Trial

  1994cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Carbohydrate fermentation decreases hepatic glucose output in healthy subjects.

  1993cited by this paper
• Interaction between methane-producing status and diet on serum acetate concentration in humans.

  1993cited by this paper
• Interactions between nutrition and the intestinal microflora

  1993cited by this paper
• Effect on blood lipids of very high intakes of fiber in diets low in saturated fat and cholesterol.

  1993cited by this paper
• Plasma lipids and lipoproteins and the prevalence of risk for coronary heart disease in Canadian adults. Canadian Heart Health Surveys Research Group.

  1992cited by this paper
• Beneficial Effect of a Low Glycaemic Index Diet in Type 2 Diabetes

  1992cited by this paper
• The Energy Values of Dietary Fibre and Sugar Alcohols for Man

  1992cited by this paper
• Oat bran increases serum acetate of hypercholesterolemic men.

  1992cited by this paper
• Therapeutic Potentials of Acarbose as First-Line Drug in NIDDM Insufficiently Treated With Diet Alone

  1991cited by this paper
• Specific types of colonic fermentation may raise low-density-lipoprotein-cholesterol concentrations.

  1991cited by this paper
• Interaction between colonic acetate and propionate in humans.

  1991cited by this paper
• The control and consequences of bacterial fermentation in the human colon.

  1991cited by this paper
• The contribution of the large intestine to blood acetate in man.

  1991cited by this paper
• Acetate tolerance and the kinetics of acetate utilization in diabetic and nondiabetic subjects.

  1990cited by this paper
• Metabolic Effects of Reducing Rate of Glucose Ingestion by Single Bolus Versus Continuous Sipping

  1990cited by this paper
• Alternative pathways for hydrogen disposal during fermentation in the human colon.

  1990cited by this paper
• Metabolic effects of reducing rate of glucose ingestion by single bolus versus continuous sipping.

  1990cited by this paper
• Idiopathic constipation by colonic dysfunction

  1989cited by this paper
• Nibbling versus gorging: metabolic advantages of increased meal frequency.

  1989cited by this paper
• Change in plasma acetate levels in diabetic subjects on mixed high fiber diets.

  1989cited by this paper
• Effect of gut-derived acetate on glucose turnover in man.

  1988cited by this paper
• Effect of gut-derived acetate on oral glucose tolerance in man.

  1988cited by this paper
• Comparison of ileal effluents, dietary fibers, and whole foods in predicting the physiological importance of colonic fermentation.

  1988cited by this paper
• Competition for hydrogen between sulphate-reducing bacteria and methanogenic bacteria from the human large intestine.

  1988cited by this paper
• Plasma acetate levels in response to intravenous fat or glucose/insulin infusions in diabetic and non-diabetic subjects.

  1988cited by this paper
• Acarbose: A Preliminary Review of its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Potential

  1988cited by this paper
• Low-glycemic index diet in hyperlipidemia: use of traditional starchy foods.

  1987cited by this paper
• Short chain fatty acids in human large intestine, portal, hepatic and venous blood.

  1987cited by this paper
• An experimental design to study colonic fibre fermentation in the rat: the duration of feeding

  1986cited by this paper
• Methanogens in human and animal intestinal Tracts

  1986cited by this paper
• The Measurement of Plasma Acetate by a Manual or Automated Technique in Diabetic and Non-Diabetic Subjects

  1986cited by this paper
• Influence of chronic lactulose ingestion on the colonic metabolism of lactulose in man (an in vivo study).

  1985cited by this paper
• alpha-Glucosidase inhibition in obesity.

  1985cited by this paper
• Excessive gas: patient perception vs reality.

  1985cited by this paper
• Gluconeogenesis from caecal propionate in the horse

  1985cited by this paper
• Effect of long‐term starvation on acetate and ketone body metabolism in obese patients

  1984cited by this paper
• Short-Chain Fatty Acid Fermentation Products of Plant Fiber Affect Glucose Metabolism of Isolated Rat Hepatocytes

  1984cited by this paper
• Effect of fatty acids on glucose production and utilization in man.

  1983cited by this paper
• Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol.

  1982cited by this paper
• Scope and Specificity of Acarbose in Slowing Carbohydrate Absorption in Man

  1981cited by this paper
• Flatulence.

  1980cited by this paper
• Effects of a glucoside-hydrolase inhibitor (Bay g 5421) on serum lipids, lipoproteins and bile acids, fecal fat and bacterial flora, and intestinal gas production in hyperlipidemic patients.

  1980cited by this paper
• Synthesis of acetate from CO2 in the cecum of some rodents

  1977cited by this paper
• Production and utilization of acetate in mammals.

  1974cited by this paper
• Formation of free acetate by isolated perfused livers from normal, starved and diabetic rats.

  1974cited by this paper

• Investigating the hypoglycaemic potential of processed apple and acarbose combination in vitro, ex vivo, and in vivo: the role of quercetin-3-glucoside in steering α-glucosidase inhibition.

  2025cites this paper
• A systematic review, meta-analysis, dose-response, and meta-regression of the effects of acarbose intake on glycemic markers in adults

  2023cites this paper
• The effect of acarbose on lipid profiles in adults: a systematic review and meta-analysis of randomized clinical trials

  2023influential citation
• The effects of acarbose treatment on cardiovascular risk factors in impaired glucose tolerance and diabetic patients: a systematic review and dose–response meta-analysis of randomized clinical trials

  2023influential citation
• Reducing the intestinal side effects of acarbose by baicalein through the regulation of gut microbiota: An in vitro study.

  2022cites this paper
• Projet SPICES : sélection parmi 5 recommandations de bonne pratique pour la prévention des maladies cardiovasculaires via les procédures AGREE II et ADAPTE. Identification des références bibliographiques des recommandations internationales, « 2013 AHA/ACC/TOS. Guideline for the Management of Overwei

  2018cites this paper
• Effects of Acarbose on the Gut Microbiota of Prediabetic Patients: A Randomized, Double-blind, Controlled Crossover Trial

  2017cites this paper
• An exploratory phenomenological study exploring the experiences of people with systemic disease who have undergone lower limb amputation and its impact on their psychological well-being

  2016cites this paper
• Factors Influencing the Input Side of Folate Nutrition

  2016cites this paper
• Natural Product Research: Formerly Natural Product Letters

  2014cites this paper
• Triterpenes as uncompetitive inhibitors of α-glucosidase from flowers of Punica granatum L.

  2014cites this paper
• Comparison of Acarbose and Voglibose in Diabetes Patients Who Are Inadequately Controlled with Basal Insulin Treatment: Randomized, Parallel, Open-Label, Active-Controlled Study

  2013cites this paper
• Inulin Increases Short-Term Markers for Colonic Fermentation similarly in Healthy and Hyperinsulinemic Humans

  2011cites this paper
• Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.

  2010cites this paper
• Adaptation of colonic fermentation and glucagon-like peptide-1 secretion with increased wheat fibre intake for 1 year in hyperinsulinaemic human subjects

  2009cites this paper
• Low glycaemic index diet and disposition index in type 2 diabetes (the Canadian trial of Carbohydrates in Diabetes): a randomised controlled trial

  2008cites this paper
• Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.

  2006cites this paper
• Acarbose ameliorates atherogenecity of low-density lipoprotein in patients with impaired glucose tolerance.

  2006cites this paper
• Pharmacological and surgical treatment of obesity.

  2004cites this paper
• Insulin, glucagon, and hypoglycemic drugs

  2003cites this paper
• Short-term effect of acarbose on specific intestinal disaccharidase activities and hyperglycaemia in CBA diabetic mice.

  2003cites this paper
• Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis.

  2003cites this paper
• Control of postprandial hyperglycaemia by galactosyl maltobionolactone and its novel anti-amylase effect in mice.

  2002cites this paper
• Do colonic short-chain fatty acids contribute to the long-term adaptation of blood lipids in subjects with type 2 diabetes consuming a high-fiber diet?

  2002cites this paper
• Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.

  2002cites this paper
• Miglitol, an α-glucosidase inhibitor, prevents the metformin-induced fall in serum folate and vitamin B12 in subjects with type 2 diabetes.

  2000cites this paper
• Marked weight loss in a type 2 diabetic patient treated with acarbose.

  1999cites this paper
• Acute Postprandial Gastrointestinal and Metabolic Effects of Wheat Amylase Inhibitor (WAI) in Normal, Obese, and Diabetic Humans

  1998cites this paper
• No Relationship Between Carbohydrate Intake and Effect of Acarbose on HbA1c or Gastrointestinal Symptoms in Type 2 Diabetic Subjects Consuming 30–60% of Energy From Carbohydrate

  1998cites this paper
• Potential of alpha-glucosidase inhibitors in elderly patients with diabetes mellitus and impaired glucose tolerance.

  1998cites this paper
• Withdrawal of insulin therapy after adjunctive treatment with acarbose in a patient with Type 2 diabetes mellitus

  1998cites this paper
• Potential of α-Glucosidase Inhibitors in Elderly Patients with Diabetes Mellitus and Impaired Glucose Tolerance

  1998cites this paper
• Time of day and glucose tolerance status affect serum short-chain fatty acid concentrations in humans.

  1997cites this paper
• alpha-Glucosidase inhibitors.

  1997cites this paper
• Acarbose enhances human colonic butyrate production.

  1997cites this paper
• Acarbose: an alpha-glucosidase inhibitor.

  1996cites this paper
• A Review of the Safety and Efficacy of Acarbose in Diabetes Mellitus

  1996cites this paper